The impact of gout on work absence and productivity

被引:95
作者
Kleinman, Nathan L.
Brook, Richard A.
Patel, Pankaj A.
Melkonian, Arthur K.
Brizee, Truman J.
Smeeding, James E.
Joseph-Ridge, Nancy
机构
[1] HCMS Grp, Cheyenne, WY 82001 USA
[2] JeSTARx Grp, Newfoundland, NJ USA
[3] TAP Pharmaceut Prod Inc, Lake Forest, IL USA
[4] Univ Texas, Ctr Pharmacoecon Studies, Austin, TX 78712 USA
关键词
absence; employee; gout; productivity;
D O I
10.1111/j.1524-4733.2007.00173.x
中图分类号
F [经济];
学科分类号
02 ;
摘要
Objective: The goal of this analysis was to evaluate the impact of gout, a painful inflammatory arthritis condition, on an employed population's health-related work absence and objectively measured productivity output. Methods: Payroll, demographic, medical, pharmaceutical, sick leave, short- and long-term disability, and workers' compensation data were collected from multiple large employers with employees widely dispersed across the United States. Data were collected during the time period of 2001 to 2004 from approximately 300,000 employees. Objective productivity output data were also available for a subset of employees (captured electronically in the form of units of work processed per person). T-tests and chi-square tests were used to compare demographic data. Two-stage multivariate regression models were used to compare annual work absence and at-work productivity between employees with and without gout, while controlling for group differences demographics, salary, other work-related variables, and comorbidities (using the Charlson Comorbidity Index). Results: The annual prevalence of gout was 4.7 per 1000 employees from 2001 to 2004. Employees with gout had 4.56 more annual absence days for all categories of health-related work absence than those without gout. Objective productivity (units of work processed) results were only available for a small subsample of employees (86 with gout and 27,472 without gout). Employees with gout processed 3.51% fewer units per hour worked and 2.38% fewer units per year than employees without gout (nonsignificant at P = 0.49 and P = 0.78, respectively). Conclusion: This study suggests that gout has a substantial impact on work absence and may also negatively impact productivity.
引用
收藏
页码:231 / 237
页数:7
相关论文
共 41 条
  • [1] [Anonymous], 2004, Clinical Classifications Software (CCS), 2004
  • [2] [Anonymous], 1999, VITAL HLTH STAT
  • [3] Arromdee E, 2002, J RHEUMATOL, V29, P2403
  • [4] On the brink of novel therapeutic options for an ancient disease
    Bieber, JD
    Terkeltaub, RA
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (08): : 2400 - 2414
  • [5] Modeling risk using generalized linear models
    Blough, DK
    Madden, CW
    Hornbrook, MC
    [J]. JOURNAL OF HEALTH ECONOMICS, 1999, 18 (02) : 153 - 171
  • [6] *CDCP, 1996, VIT HLTH STAT CURR E, V10
  • [7] *CDCP, 1988, VIT HLTH STAT CURR E, V10
  • [8] A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION
    CHARLSON, ME
    POMPEI, P
    ALES, KL
    MACKENZIE, CR
    [J]. JOURNAL OF CHRONIC DISEASES, 1987, 40 (05): : 373 - 383
  • [9] A single-blind, randomized, controlled trial to assess the efficacy and tolerability of rofecoxib, diclofenac sodium, and meloxicam in patients with acute gouty arthritis
    Cheng, TT
    Lai, HM
    Chiu, CK
    Chen, YC
    [J]. CLINICAL THERAPEUTICS, 2004, 26 (03) : 399 - 406
  • [10] Obesity, weight change, hypertension, diuretic use, and risk of gout in men - The health professionals follow-up study
    Choi, HK
    Atkinson, K
    Karlson, EW
    Curhan, G
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (07) : 742 - 748